Episode 273: Journal Club 5: A Re-Analysis of KetoMed
Low Carb MD Podcast
Drs. Brian Lenzkes & Tro Kalayjian
4.8 • 1.2K Ratings
🗓️ 5 April 2023
⏱️ 48 minutes
🧾️ Download transcript
Summary
Thank you for joining us for another episode of the Low Carb MD Podcast.
Dr. Laura Buchanan is board certified in Family Medicine and is on the board of the Society of Metabolic Health Practitioners. She graduated summa cum laude with a Bachelor of Science in Biomedical Sciences from the University of South Florida and was a valedictorian of her class at the University of Florida College of Medicine. She is on staff at Dr. Tro's Medical Weight Loss & Direct Primary Care.
Dr. Matt Calkins is an emergency medicine resident who loves studying the science of longevity, the optimization of all phases of health, and applying his knowledge to physician and patient wellness. Matt earned his M.D. from the University of Florida and holds a B.Sc. in physics.
In this episode, Drs. Tro, Matt, and Laura talk about The Keto-Med Trial which compared different formulations of the low-carb diet. They examine the methods, data, and conclusions of the study and give their assessments.
For more information, please see the links below. Thank you for listening!
Links:
Dr. Matt Calkins:
Dr. Laura Buchanan:
Dr. Tro Kalayjian:
Dr. Brian Lenzkes:
Doctor Tro App
Join a growing community of individuals who are improving their metabolic health; together.
Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to the low-carb MD podcast. No one is beyond help. No one is beyond hope. |
| 0:07.4 | As we have always said we are bringing you medical information and cutting-edge |
| 0:11.5 | science, but none of this is medical advice. Please seek out input from your own |
| 0:18.1 | doctor. |
| 0:20.5 | Welcome back to the podcast. I am here for another journal club episode with Dr. |
| 0:31.6 | Laura Buchanan, who's now been with our practice for over six months and it's |
| 0:36.6 | been such a pleasure to work with her. Her counterpart, Dr. Matt Cawkins. Guys, |
| 0:43.2 | I am so excited. We're going to be talking about something near and dear to my |
| 0:47.2 | heart, something that struck me so, you know, so powerfully that I had to write a |
| 0:54.5 | letter to the editor. So this is, this is going to be an exciting day. So Dr. Laura, |
| 1:00.5 | what are we talking about? Good morning. I'm excited to be here. So first we're |
| 1:05.3 | going to discuss the keto med trial and I'll actually go ahead and share my |
| 1:08.3 | screen. So this got a lot of headlines when it came out. Yeah, so we should talk |
| 1:14.2 | about some of these headlines because, you know, this study was done by Christopher |
| 1:20.3 | Gardner. He's a very well-respected researcher from Stanford who's looked into |
| 1:25.4 | nutrition for the past two or three decades. In fact, he's so well respected in |
| 1:31.6 | the field that he is now part of the guidelines committee for 2025. He's done |
| 1:41.4 | several notable studies that have supported low carb in the past and it seems |
| 1:46.9 | like over the last 10 years there's been this subtle effort to undermine some |
| 1:52.1 | of those findings and the keto med study was done during the pandemic. So we, you |
| 2:00.4 | know, there's some, some pause and some applaud should be given to actually |
| 2:05.1 | doing a study like this. But some of the conclusions actually infuriated me. I |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Drs. Brian Lenzkes & Tro Kalayjian, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Drs. Brian Lenzkes & Tro Kalayjian and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.